Adrenocortical carcinoma (ACC) is an uncommon aggressive endocrine malignancy that is
nonetheless associated with significant mortality and morbidity rates because of endocrine …

Adrenocortical carcinoma (ACC) is a highly malignant infrequent tumor with a dismal
prognosis. microRNAs (miRNAs, miRs) are crucial in post-transcriptional gene expression …

Simple Summary Cancer is a complex disease associated with deregulation of numerous
genes. In addition, redundant cellular pathways limit efficiency of monotarget drugs in …

Adrenocortical carcinomas (ACCs) are aggressive cancers originating in the cortex of the
adrenal gland. Despite overall poor prognosis, ACC outcome is heterogeneous,. We …

Objective Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis.
Herein, we describe the clinical features and outcomes for a large series of ACC patients …

Background The advantages and utility of microRNAs (miRNAs) as diagnostic and
prognostic cancer markers is at the vanguard in recent years. In this study, we attempted to …

Pheochromocytoma (PCC) is a neuroendocrine tumor that produces and secretes
catecholamine from either the adrenal medulla or extra-adrenal locations. MicroRNAs …

It has been reported that expression of glucose transporter member 3 (GLUT3) is up-
regulated in bladder cancers. However, the regulating mechanism remains unknown. Here …

Adrenocortical carcinoma is a rare malignancy with an annual worldwide incidence of 1–2
cases per 1 million and a 5-year survival rate of< 60%. Although adrenocortical carcinoma is …

All lung cancers patients with epidermal growth factor receptor (EGFR) mutation inevitably
develop acquired resistance to EGFR tyrosine kinase inhibitors (TKI). In up to 30% of cases …